We also found that the forced expression of the SHP-2 mutant promoted MEK activation and malignancy in the parental NF1-MPNST cells, and that these effects of the SHP-2 mutant were attenuated by the forced expression of the BRAP mutant. The gene discussed is MAP2K7; the disease is malignant peripheral nerve sheath tumor.